President John Dramani Mahama has declared that Africa’s long-standing ambition to establish a robust pharmaceutical manufacturing industry is moving from policy discussions to implementation, urging leaders across the continent to accelerate efforts to reduce dependence on imported medicines.
Speaking at the second day of the African Union Extraordinary Summit, Mahama said Africa’s pharmaceutical manufacturing agenda was no longer “a mere scribble on paper” but a vision steadily taking shape through renewed political commitment and investment.
He said the continent’s continued reliance on imported medicines and medical supplies exposed African countries to serious health and economic risks, making the expansion of local pharmaceutical production an urgent priority.
According to the President, strengthening domestic manufacturing capacity is essential not only for improving health security but also for driving industrialisation, creating jobs and supporting long-term economic transformation.
Mahama also expressed concern over declining international development assistance for health, warning that many African countries still depend heavily on external funding to sustain their healthcare systems.
He described the changing global financing landscape as a critical moment for African governments to pursue self-reliance by investing in homegrown solutions capable of strengthening public health systems.
The President argued that health spending should no longer be viewed solely as a social obligation but as a strategic economic investment capable of stimulating growth, expanding employment opportunities and building resilient economies.
He urged African leaders to move beyond declarations and implement practical measures that would strengthen local pharmaceutical production, improve access to essential medicines and reduce the continent’s vulnerability to global supply disruptions.
Calling for collective action, Mahama appealed to African Heads of State, health ministers, policymakers and development partners to translate their commitments into measurable outcomes.
He said the future of healthcare on the continent would depend on bold leadership and decisive investments that support Africa’s pharmaceutical industry and ensure sustainable health security for its people.




